Skip to content

Interest Paid at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$23.42M+226%
Insmed logo
InsmedINSM
$13.12M0.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$3.63M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.45M+11.8%
uniQure logo
uniQureQURE
$6.72M+3.5%
Scholar Rock logo
Scholar RockSRRK
$2.37M+57.9%

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$872.26M+135%
Enterprise value$595.83M+223%
P/S107.8×-9.9×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s interest paid?
Solid Biosciences Inc. (SLDB) reported interest paid of $0 in Q1 2026.
How has Solid Biosciences Inc.'s interest paid changed year-over-year?
Solid Biosciences Inc.'s interest paid decreased by 100.0% year-over-year, from $68K to $0.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.